MARISSA FOX: Open Payments
NPI 1356970883 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,720 in 64 payments from 10 companies in 2025. Trend: 2023 $424 · 2024 $2,517 · 2025 $1,720
Food & beverage: $1,720
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 26 | $769 |
| ViiV Healthcare Company | 20 | $484 |
| Merck Sharp & Dohme LLC | 5 | $148 |
| ABBVIE INC. | 4 | $123 |
| Napo Pharmaceuticals Inc | 4 | $103 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: APRETUDE, CABENUVA, PIFELTRO, Mytesi, VRAYLAR, MAVYRET, GARDASIL 9, RUKOBIA.
Industry payments across CA — which companies pay providers there.
